Ibrutinib

Ibrutinib, also known by its brand name Imbruvica, is a medication used to treat certain blood cancers like Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL). It works by blocking a specific protein called BTK, which helps slow the growth of cancer cells. While effective, Ibrutinib can sometimes affect other parts of the body, potentially leading to side effects such as an irregular heartbeat (atrial fibrillation) or easy bruising. Understanding how this medication relates to your treatment and how to manage its effects is important for your health. In this topic, you can find supportive information to help you learn more and discuss Ibrutinib with your healthcare team.